X. Tong

发表

Functional characterization of somatic point mutations of the human estrogen receptor alpha (hERalpha) in adenomyosis uteri.

D. Kieback, M. Oehler, H. Greschik, 2004, Molecular human reproduction.

Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro.

S. Lerner, X. Tong, D. Kieback, 2003, Urologic oncology.

A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.

D. Edwards, N. Weigel, D. Kieback, 2004, The Journal of clinical endocrinology and metabolism.

Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines

R. Kreienberg, I. Runnebaum, D. Kieback, 1994, Human Genetics.

p53 mutant His175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6

R. Kreienberg, I. Runnebaum, D. Kieback, 1994, FEBS Letters.

Subcellular localization of accumulated p53 in ovarian cancer cells.

R. Kreienberg, I. Runnebaum, D. Kieback, 1996, Gynecologic oncology.

Molecular aspects of ovarian cancer. Is gene therapy the solution?

R. Ramesh, S. Freeman, D. Kieback, 1999, Hematology/oncology clinics of North America.

Comparison of Long-term Survival of Cytomegalovirus Promoter versus Rous Sarcoma Virus Promoter-Driven Thymidine Kinase Gene Therapy in Nude Mice Bearing Human Ovarian Cancer

C. Contant, A. Hasenburg, D. Kieback, 1999 .

Periostin Secreted by Carcinoma-Associated Fibroblasts Promotes Ovarian Cancer Cell Platinum Resistance Through the PI3K/Akt Signaling Pathway

Jun Xu, X. Tong, Lei Chu, 2020, Technology in cancer research & treatment.

Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer

I. Ramzy, A. Hasenburg, D. Kieback, 2000, Cancer Gene Therapy.

A Genetic Mutation in the Progesterone Receptor (PROGINS) leads to an increased risk of non-familial breast and ovarian cancer causing inadequate control of estrogen receptor driven proliferation

N. Weigel, D. Kieback, I. Agoulnik, 1998 .

Adenovirus-Mediated Thymidine Kinase Gene Therapy for Recurrent Ovarian Cancer: Expression of Coxsackie-Adenovirus Receptor and Integrins αvβ3 and αvβ5

I. Ramzy, A. Hasenburg, D. Kieback, 2002, The Journal of the Society for Gynecologic Investigation: JSGI.

Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up.

I. Ramzy, A. Hasenburg, D. Kieback, 2001, Gynecologic oncology.

Expression of aryl hydrocarbon receptor in relation to p53 status and clinicopathological parameters in breast cancer.

X. Tong, Zhigang Zhuang, Kai Wang, 2014, International Journal of Clinical and Experimental Pathology.

Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer

I. Ramzy, A. Hasenburg, D. Fischer, 2001, International Journal of Gynecologic Cancer.

Coxsackievirus–adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression

A. Hasenburg, D. Kieback, D. Fischer, 2001, Cancer Gene Therapy.

Chicken ovalbumin upstream promoter--transcription factor (COUP-TF) expression in human endometrial cancer cell lines.

M. Tsai, I. Runnebaum, M. Press, 1996, Anticancer Research.

Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment.

I. Ramzy, A. Hasenburg, D. Kieback, 1999, Anticancer research.

Gene Therapy of Ovarian Cancer—State-of-the-Art and Future Perspectives

I. Runnebaum, A. Hasenburg, D. Kieback, 2003 .

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

W. Sauerbrei, D. Kieback, M. Oehler, 2002, Cancer Gene Therapy.

p53 gain-of-function mutation in codon 175 is a rare event in human breast cancer.

R. Kreienberg, I. Runnebaum, D. Kieback, 1993, Human molecular genetics.

Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir.

D. Kieback, S. Woo, X. Tong, 1996, Anticancer research.

Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy.

C. Contant, A. Hasenburg, D. Kieback, 1998, Anticancer research.

Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy.

K. Blankenburg, C. Contant, E. Stickeler, 1997, Anticancer research.

Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents.

A. Hasenburg, D. Kieback, S. Woo, 1998, Anticancer research.

In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration.

K. Blankenburg, C. Contant, D. Kieback, 1996, Gynecologic oncology.

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5.

I. Ramzy, A. Hasenburg, D. Kieback, 2002, Journal of the Society for Gynecologic Investigation.

Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.

C. Contant, S. Lerner, D. Kieback, 2000, Anticancer research.

p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer

R. Kreienberg, E. Atkinson, I. Runnebaum, 1995, The Lancet.

A mutated progesterone receptor allele is more prevalent in unexplained infertility.

M. Pisarska, D. Kieback, S. Carson, 2003, Fertility and Sterility.

Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients.

E. Atkinson, I. Runnebaum, E. Stickeler, 1998, Anticancer research.

The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter.

C. Contant, Z. Guo, A. Hasenburg, 1998, Anticancer research.

Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients.

R. Kreienberg, I. Runnebaum, S. Maier, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Expression levels of hnRNP G and hTra2‐beta1 correlate with opposite outcomes in endometrial cancer biology

Markus Jäger, Elmar Stickeler, Marc Hirschfeld, 2011, International journal of cancer.